Post job

Elicio Therapeutics's revenue is $1.1 million.

What is Elicio Therapeutics's revenue?

Elicio Therapeutics's annual revenue is $1.1M. Zippia's data science team found the following key financial metrics about Elicio Therapeutics after extensive research and analysis.
  • Elicio Therapeutics has 26 employees, and the revenue per employee ratio is $42,308.
  • Elicio Therapeutics peak revenue was $1.1M in 2024.

On this page

Peak revenue
$1.1M (2024)
Company peak revenue
Revenue / employee
$42,308
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$1.1M (2024)
Company peak revenue
Revenue / employee
$42,308
Company revenue / employee

Elicio Therapeutics financing

Elicio Therapeutics received early financing of $3.3M on 2012-08-03.

SeriesRound sizeDate
Series Unknown$3.3M08/2012
Series Unknown$750K05/2016
Series Unknown$30M03/2019
Series B$33M10/2019
Series Unknown$8.4M03/2020
Series B$73M02/2021

Elicio Therapeutics investors

InvestorsSecurity type
Access BridgeGap VenturesSeries Unknown
Livzon Pharmaceutical GroupSeries B
Clal Biotechnology IndustriesSeries B
Efung CapitalSeries B

Elicio Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Elicio Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Elicio Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Elicio Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Elicio Therapeutics. The data presented on this page does not represent the view of Elicio Therapeutics and its employees or that of Zippia.

Elicio Therapeutics may also be known as or be related to Elicio Therapeutics, Elicio Therapeutics Inc. and Elicio Therapeutics, Inc.